70 related articles for article (PubMed ID: 8907632)
1. Peripheral blood CD34+ cells: method of purification and ex vivo expansion.
Bohbot A; Feugeas O; Cuillerot JM; Grosse A; Rusciani I; Faradji A; Oberling F
Nouv Rev Fr Hematol (1978); 1995; 37(6):359-65. PubMed ID: 8907632
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
3. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
[TBL] [Abstract][Full Text] [Related]
4. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
5. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.
Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M
Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838
[TBL] [Abstract][Full Text] [Related]
7. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
8. Expansion of blood CD34 positive cells: committed precursors expansion does not affect immature hematopoietic progenitors.
David S; Rice A; Vianes I; Duperray V; Dupouy M; Reiffers J
Nouv Rev Fr Hematol (1978); 1995; 37(6):343-9. PubMed ID: 8907630
[TBL] [Abstract][Full Text] [Related]
9. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
[TBL] [Abstract][Full Text] [Related]
10. Separation of chemotherapy plus G-CSF-mobilized peripheral blood mononuclear cells by counterflow centrifugal elutriation: in vitro characterization of two different CD34+ cell populations.
Teofili L; Rutella S; Pierelli L; Ortu la Barbera E; Di Mario A; Menichella G; Rumi C; Leone G
Bone Marrow Transplant; 1996 Aug; 18(2):421-5. PubMed ID: 8864456
[TBL] [Abstract][Full Text] [Related]
11. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
[TBL] [Abstract][Full Text] [Related]
12. [Ex vivo increase in hematopoietic progenitor cells for clinical use].
Arseniev L; Battmer K; Stucki A; Südmeyer I; Kadar JG; Martin M; Link H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():50-9. PubMed ID: 8692120
[TBL] [Abstract][Full Text] [Related]
13. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
[TBL] [Abstract][Full Text] [Related]
14. In vitro expansion of CD34+ cells from peripheral blood of myeloma and lymphoma patients.
Mahe B; Menard A; Accard F; Pineau D; Robillard N; Hermouet S
Nouv Rev Fr Hematol (1978); 1995; 37(6):335-41. PubMed ID: 8907629
[TBL] [Abstract][Full Text] [Related]
15. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
Haas R; Murea S
Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
[TBL] [Abstract][Full Text] [Related]
16. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
17. Promotion of differentiation and proliferation of peripheral blood CD34+ cells in vitro by G-CSF.
Xu J; Arimori S; Kobayashi N; Nakamura Y; Takei M; Arahira Y
Chin Med J (Engl); 1996 May; 109(5):372-5. PubMed ID: 9208494
[TBL] [Abstract][Full Text] [Related]
18. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
19. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
[TBL] [Abstract][Full Text] [Related]
20. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
